Navigation Links
Steroid Use Fails to Boost Pregnancy Rates in Infertility Treatments

There is no clear benefit from a hormone commonly prescribed to enhance the effectiveness of infertility treatments//, according to a new review of studies.

The steroid hormones called glucocorticoids have potent effects on the body’s inflammatory and immune responses, so many fertility specialists prescribe them in hopes of making the lining of the uterus more receptive to embryo implantation. But lead review author Carolien Boomsma says that routine practice should stop.

“This meta-analysis shows that empirical use of glucocorticoids is not supported by evidence from studies,” she said. “Moreover, we don’t know enough about the possible adverse effects of glucocorticoids in early pregnancy. Therefore, at present, glucocorticoids should not be prescribed in this way,” said Boomsma, a researcher at the University Medical Centre Utrecht in the Netherlands.

The review appears in the most recent issue of The Cochrane Library, a publication of The Cochrane Collaboration, an international organization that evaluates medical research. Systematic reviews draw evidence-based conclusions about medical practice after considering both the content and quality of existing medical trials on a topic.

The review compares success rates between would-be mothers who took glucocorticoids around the time of embryo implantation and those who did not. All of the women underwent one of two types of assisted reproductive technology. In vitro fertilization (IVF) involves removing mature eggs from a woman’s ovary, mixing them with sperm in the laboratory, and placing the embryos in the woman’s reproductive tract. Intracytoplasmic sperm injection (ICSI) is another in vitro fertilization practice where a single sperm is injected directly into a harvested egg.

The meta-analysis pooled data from 13 studies including 1,759 couples. Every study was a randomized controlled trial, which is considered the most reliable form of scientific evid
'"/>




Page: 1 2 3

Related medicine news :

1. Inhaled Steroids Safe & Effective for Children with Asthma
2. Mislabeled Body-building Steroid Supplements
3. Steroid Treatment for Wheezing Questioned
4. Steroid-Free Liver Transplants
5. The Use Of Steroids for Dizziness Questioned
6. Biofeedback Found To Reduce Steroid Dependence In Asthmatics
7. Steroid Treatment after head injury may be fatal
8. The Link Between High-dose Steroid Use And Heart Disease Questioned
9. The Use Of Oral Steroids For Muscular Dystrophy Questioned
10. No Steroids for Traumatic Brain Injury
11. Steroids Effective For Treating Carpel Tunnel Syndrome
Post Your Comments:
(Date:12/14/2009)... ,, NEW YORK, Dec. 14 /PRNewswire-USNewswire/ ... study (MTF) -- the largest survey on teen drug ... -- underscores that teens, intentional abuse of prescription (Rx) ... for concern, with an alarming number of young people ... ,, Teen Abuse of Medication Continues to ...
(Date:12/14/2009)... 14 The Hemophilia Federation of America ... issues involving the Teamsters Local 929 and the ... national blood system depends on skilled workers to ... is distilled into products such as clotting factor ... disease. ,, The Division of Blood Services ...
(Date:12/14/2009)... Exercise benefited men whose disease had been treated, hadn,t ... -- Exercise appears to reduce the risk of death ... study, which began in January 1986, included 668 men ... stage III colon cancer that had not spread (nonmetastatic ... that asked them about any new cancer and disease ...
(Date:12/14/2009)... protection, study finds, , , MONDAY, Dec. 14 (HealthDay News) ... their morning without a cup or two of java: ... developing type 2 diabetes. , That,s the conclusion ... coffee you drink, the lower your risk of diabetes. ... percent reduction in the risk of diabetes, the researchers ...
(Date:12/14/2009)... are underdiagnosed, poorly treated and highly stigmatized, according ... H. Rubin, M.D., Ph.D. So these Washington University ... problems. , In "Demystifying Psychiatry," Zorumski and Rubin, ... treating psychiatric patients and helping patient families, say ... and treatment result from a lack of understanding ...
Breaking Medicine News(10 mins):Health News:Partnership for a Drug-Free America(R) Responds to 2009 Monitoring the Future Study Results 2Health News:Partnership for a Drug-Free America(R) Responds to 2009 Monitoring the Future Study Results 3Health News:HFA Voices Blood Safety Concerns 2Health News:Physical Activity May Prolong Survival After Colon Cancer 2Health News:Coffee, Tea Might Stave Off Diabetes 2Health News:Coffee, Tea Might Stave Off Diabetes 3Health News:Book demystifies psychiatry for the general public 2Health News:Book demystifies psychiatry for the general public 3
... Environmentalists want bisphenol A banned from products for infants ... organizations in the United States and Canada are calling ... bisphenol A (BPA) in baby bottles, toddler sippy cups, ... "This is quite concerning. All 19 polycarbonate bottles [investigated ...
... be getting an,unfair rap for disrupting women,s sleep at ... increase during the,transition into menopause, reinforcing the idea that ... in sleep laboratories, the,connection between hot flashes and sleep ... Women,s Health Watch., A new study concludes that ...
... -- A new study by researchers at Northwestern University,s ... how best to treat patients in respiratory distress in ... believed that high levels of carbon dioxide (CO2) or ... acute lung disease may be beneficial to them. Now, ...
... LAS VEGAS, Feb. 7 American Pacific,Corporation (Nasdaq: ... quarter ended December 31, 2007., We provide non-GAAP ... A reconciliation of the non-GAAP measures to the most ... data., FINANCIAL HIGHLIGHTS, Quarter Ended December 31, ...
... episode, OAKLAND, Calif., Feb. 7 Nytera Tilmon ... care for her seven children,all of whom live with ... a new television show revealing Nytera,s story and others,behind ... is,called "Union Time" and it,s the only national labor-produced ...
... After just seven months in print, Cell Stem Cell, ... New Journal - Science, Technology & Medicine, by the Professional ... Publishers (AAP). , This honor, which is among the Association ... a year after Cell Stem Cell published its first issue ...
Other Medicine News:Health News:Report Shows Dangerous Chemical Can Leach From Baby Bottles 2Health News:Report Shows Dangerous Chemical Can Leach From Baby Bottles 3Health News:Hot Flashes Not Always to Blame for Sleep Problems in Menopausal Women, Reports the Harvard Women's Health Watch 2Health News:American Pacific Reports Revenue Increase of 34% and Net Income of $2.9 Million for Fiscal 2008 First Quarter 2Health News:American Pacific Reports Revenue Increase of 34% and Net Income of $2.9 Million for Fiscal 2008 First Quarter 3Health News:American Pacific Reports Revenue Increase of 34% and Net Income of $2.9 Million for Fiscal 2008 First Quarter 4Health News:American Pacific Reports Revenue Increase of 34% and Net Income of $2.9 Million for Fiscal 2008 First Quarter 5Health News:American Pacific Reports Revenue Increase of 34% and Net Income of $2.9 Million for Fiscal 2008 First Quarter 6Health News:American Pacific Reports Revenue Increase of 34% and Net Income of $2.9 Million for Fiscal 2008 First Quarter 7Health News:American Pacific Reports Revenue Increase of 34% and Net Income of $2.9 Million for Fiscal 2008 First Quarter 8Health News:American Pacific Reports Revenue Increase of 34% and Net Income of $2.9 Million for Fiscal 2008 First Quarter 9Health News:American Pacific Reports Revenue Increase of 34% and Net Income of $2.9 Million for Fiscal 2008 First Quarter 10Health News:American Pacific Reports Revenue Increase of 34% and Net Income of $2.9 Million for Fiscal 2008 First Quarter 11Health News:American Pacific Reports Revenue Increase of 34% and Net Income of $2.9 Million for Fiscal 2008 First Quarter 12Health News:American Pacific Reports Revenue Increase of 34% and Net Income of $2.9 Million for Fiscal 2008 First Quarter 13Health News:American Pacific Reports Revenue Increase of 34% and Net Income of $2.9 Million for Fiscal 2008 First Quarter 14Health News:American Pacific Reports Revenue Increase of 34% and Net Income of $2.9 Million for Fiscal 2008 First Quarter 15Health News:American Pacific Reports Revenue Increase of 34% and Net Income of $2.9 Million for Fiscal 2008 First Quarter 16Health News:American Pacific Reports Revenue Increase of 34% and Net Income of $2.9 Million for Fiscal 2008 First Quarter 17Health News:American Pacific Reports Revenue Increase of 34% and Net Income of $2.9 Million for Fiscal 2008 First Quarter 18Health News:American Pacific Reports Revenue Increase of 34% and Net Income of $2.9 Million for Fiscal 2008 First Quarter 19Health News:Cell Stem Cell named 'Best New Journal' of 2007 2
(Date:12/14/2009)... Tenn., Dec. 14 Embarrassing and sometimes uncomfortable ... National researchers are taking note of a new ... approval process. The Knoxville-based company, EDP Biotech ... revolutionary, ColoMarker, an affordable medical device doctors can use ... sample. "When you consider that 30% of colon ...
(Date:12/14/2009)... Calif., Dec. 14 Alexza Pharmaceuticals, Inc. (Nasdaq: ... its New Drug Application (NDA) for Staccato® loxapine (AZ-004) ... AZ-004 is an inhalation product candidate being developed for ... or bipolar disorder. The IND for Staccato ... 2005. ,, "AZ-004 has delivered a predictable and consistent ...
(Date:12/14/2009)... 14 Corgenix Medical Corporation (OTC ... marketer of diagnostic test kits, and BG ... sciences company, announced today a supply agreement ... products in enzyme-linked immunosorbent assay (ELISA) microtiter ... is seeking regulatory clearance in the United ...
Breaking Medicine Technology:EDP Biotech Takes Next Step in the Development of ColoMarker 2EDP Biotech Takes Next Step in the Development of ColoMarker 3Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA 2Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA 3Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA 4Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA 5Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA 6Corgenix and BG Medicine Announce Supply Agreement for BGM Galectin-3(TM) 2Drug ads ineffective for boosting sales could cost taxpayers 3A UBC Harvard study 61994 1Drug ads ineffective for boosting sales could cost taxpayers 3A UBC Harvard study 61994 2The cause behind the characteristic shape of a long leaf revealed 10881 1The cause behind the characteristic shape of a long leaf revealed 10881 2Water droplets direct self assembly process in thin film materials 14949 1Water droplets direct self assembly process in thin film materials 14949 2
... SAN FRANCISCO, Oct. 26 Semafore Pharmaceuticals Inc.,announced ... at the 2007,AACR-NCI- EORTC International Conference in San ... synergistic effects,with certain standard chemotherapy agents in vitro ... showed significant (p<0.001) synergistic growth,inhibition of prostate cancer ...
... 25 Paratek Pharmaceuticals, Inc. announced,today that ... a $40 million private,financing. Aisling Capital led ... D.E. Shaw and Boston Life Science Venture ... BioVentures, BioFund,Ventures, HBM BioVentures, Lombard Odier Darier ...
Other Medicine Technology:Semafore's PI3 Kinase Inhibitor SF1126 is Active Against Tumor and Tumor Cells and Synergizes with Standard Chemotherapy Agents 2Paratek Pharmaceuticals Announces the Close of $40 Million Private Placement to Finance Programs to Combat MRSA Infections 2Paratek Pharmaceuticals Announces the Close of $40 Million Private Placement to Finance Programs to Combat MRSA Infections 3Paratek Pharmaceuticals Announces the Close of $40 Million Private Placement to Finance Programs to Combat MRSA Infections 4
CVC 223 is an assayed quality control material used for confirming the calibration and linearity of CO-Oximeter instrumentation....
... assayed quality control material used for monitoring the ... It is for specific use on Bayer analyzers ... 288, and 270) and the AVOX Systems CO-Oximeters ... used on the IRMA TRUpoint®. CC 527 is ...
... QC 623 is an assayed quality control material ... available in four (4) levels for monitoring analyzer ... It may be used on multiple test analyzers ... the Radiometer 600). QC623 is also for use ...
Equinox is a truly unique approach to cosmetic enhancement contact lenses and is worn as a conventional wear lens....
Medicine Products: